熱點掃描 | 煤炭股拉昇，蒙古焦煤漲超10%
uSMART盈立智投3月28日消息，截止發稿，港股三大指數齊漲，恆生指數上漲1.44%，報21710.71點，成交額751.11億；國企指數上漲1.85%，報7420.62點，成交額305.23億；紅籌指數上漲0.01%，報3934.35點，成交額34.78億。
煤炭股拉昇，中國神華漲近9%，蒙古焦煤漲超10%，中煤能源漲超6%，伊泰煤炭、兗礦能源漲超4%；
教育股走強，中國東方教育漲超12%，天立教育漲超10%，宇華教育、中教控股、新高教集團漲超7%，思考樂教育、新東方在線漲超2%；
化肥股全線上漲，心連心化肥漲超7%，中海石油化學漲超4%，中化化肥上漲3.1%；
半導體板塊走強，芯智控股漲超9%，上海復旦漲4.7%，ASM太平洋漲3.3%，中芯國際漲2.2%，華虹半導體漲1.8%；
熱門股
騰訊盤中漲3.7%，報370港元，根據港交所文件，騰訊控股3月25日以352.8-365港元的價格回購了約83.8萬股股票，耗資約3億港幣；
美團拉昇漲近12%至151港元，美團上週五盤後公佈的財報顯示，Q4營收495.23億元，同比增長30.6%，且高於市場預期的491.98億元；Q4期內虧損53.4億元，市場預期虧損72.2億元；
森鬆國際漲近6%，現報7.83港元，上週五晚公告，2021年營業額42.79億元人民幣(下同)，按年升43.7%；純利3.81億元，按年升31.5%；每股盈利0.43元。浙商證券點評稱，公司在2021年新增訂單景氣增長、盈利能力和營運效率持續提升，看好公司製藥、新能源裝備領域的高增長，和全流程、國際化競爭力提升。維持“增持”評級；
歐康維視生物漲5.31%，報10.12港元，該公司3月25日盤後發佈公告，截至2021年12月31日止年度，公司收益爲人民幣5614.6萬元，同比增長328.73%；年內虧損爲人民幣2.60億元，去年同期則虧損爲22.65億元，基本每股虧損爲人民幣0.43分。公告稱，收益增加乃主要歸因於(i)眼科產品(即歐沁®、酒石酸溴莫尼定滴眼液、OT-401及康姝)的銷售額大幅增加，主要是由於公司在醫院營銷及推廣該等產品的工作進展順利；及(ii)有關埃美丁®及貝特舒®的以銷售爲基礎的特許權使用費收入增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
